Health | WPN World People News

On November 26, 2021, the World Health Organization (WHO) classified a new variant, B.1.1.529, as a Variant of Concern and has named it Omicron. No cases of this variant have been identified in the U.S. to date. CDC is following the details of this new variant, first reported to the WHO by South Africa. We are grateful to the South African government and its scientists who have openly communicated with the global scientific community and continue to share information about this variant with the U.S. Department of Health and Human Services and CDC. We are working with other U.S. and global public health and industry partners to learn more about this variant, as we continue to monitor its path.

Riluzole, a drug approved to treat amyotrophic lateral sclerosis (ALS), a disease affecting nerve cells controlling movement, could slow the gradual loss of a particular brain cell that occurs in Niemann-Pick disease type C1 (NPC1), a rare genetic disorder affecting children and adolescents, suggests a study in mice by scientists at the National Institutes of Health.

WHO has released a new toolkit to enable countries to accelerate their ongoing efforts to fully adopt WHO guidelines and transition to new HIV testing algorithms.

A new report published by WHO in the lead-up to World Diabetes Day on 12 Nov. 2021 highlights the alarming state of global access to insulin and diabetes care, and finds that high prices, low availability of human insulin, few producers dominating the insulin market and weak health systems are the main barriers to universal access.

The European Commission’s Joint Research Centre (JRC) and the World Health Organization (WHO) concluded a Collaborative Research Arrangement that aims to mainstream behavioural insights into public health programmes and policies worldwide. Behavioural insights can help improve understanding on how and why people behave in ways that affect their health, and help design policies and services that address behavioural factors for improved physical and mental well-being.

The pandemic has highlighted the importance of partnerships in responding to health emergencies. The WHO Information Network for Epidemics (EPI-WIN) team is spotlighting partnerships between WHO, faith partners and national governments in the global conference Strengthening National Responses to Health Emergencies co-hosted with Religions for Peace.

A group of 50 countries have committed to develop climate-resilient and low-carbon health systems at the UN Climate Change Conference in Glasgow (COP26), in response to growing evidence of the impact of climate change on people’s health.

A group of 50 countries have committed to develop climate-resilient and low-carbon health systems at the UN Climate Change Conference in Glasgow (COP26), in response to growing evidence of the impact of climate change on people’s health.

On Nov. 3rd 2021, the World Health Organization (WHO) issued an emergency use listing (EUL) for COVAXIN® (developed by Bharat Biotech), adding to a growing portfolio of vaccines validated by WHO for the prevention of COVID-19 caused by SARS-CoV-2.

H.E. Anthony Thomas Aquinas Carmona, former President of Trinidad and Tobago, Dr. Hong Tao-Tze, H.E. Yusuf Abdulkarim Bucheeriu, Ambassador of Bahrain to the United Nations in Vienna, singed the Declaration of the International Day of Conscience